The influence of automated plateletpheresis on systemic levels of hematopoietic growth factors

Transfusion

Volumn 39, Issue 8, 1999, Pages 889-894

  Weisbach, Volker ^a,b   Friedlein, H ^a   Glaser, A ^a   Zingsem, J ^a   Zimmermann, R ^a   Eckstein, R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; STEM CELL FACTOR; THROMBOPOIETIN;

ADULT; APHERESIS; ARTICLE; AUTOMATION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; MALE; MEGAKARYOPOIESIS; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOCYTOPOIESIS;

ADOLESCENT; ADULT; BLOOD DONORS; ERYTHROPOIETIN; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; PLATELET COUNT; PLATELETPHERESIS; STEM CELL FACTOR; THROMBOPOIETIN;

EID: 0033360884     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39080889.x     Document Type: Article

References (24)

1. Dettke M, Hlousek M, Kurz M, et al. Increase in endogenous thrombopoietin in healthy donors after automated plateletpheresis. Transfusion 1998;38:449-53.
2. Stohlawetz P, Stiegler G, Jilma B, et al. Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis. Transfusion 1998;38:454-8.
3. Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A 1994;91:11104-8.
4. De Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-8.
5. Hamblin T. Cytokines to reduce platelet transfusions: non-TPO cytokines. Transfus Sci 1997;18:121-8.
6. Caracciolo D, Clark SC, Rovera G. Human interleukin-6 supports granulocytic differentiation of hematopoietic pro-genitor cells and acts synergistically with GM-CSF. Blood 1989;73:666-70.
7. Inoue H, Kadoya T, Kabaya K, et al. A highly enhanced thrombopoietic activity by monomethoxy polyethylene glycol-modified recombinant human interleukin-6. J Lab Clin Med 1994;124:529-36.
8. Van Gameren MM, Willemse PH, Mulder NH, et al. Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 1994;84:1434-41.
9. Chow FP, Zsebo K, Hamburger AW. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice. Exp Hematol 1993;21:1255-62.
10. Heyworth CM, Whetton AD, Nicholls S, et al. Stem cell factor directly stimulates the development of enriched granulocyte-macrophage colony-forming cells and promotes the effects of other colony-stimulating factors. Blood 1992;80:2230-6.
11. Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995;85:1719-26.
12. Kovacs CJ, Powell DS, Evans MJ, et al. Enhanced platelet recovery in myelosuppressed mice treated with interleukin-1 and macrophage colony-stimulating factor: potential interactions with cytokines having megakaryocyte colony-stimulating activity. J Interferon Cytokine Res 1996;16:187-94.
13. Scientific Advisory Board of the German Medical Association and the Paul Ehrlich Institute. |Guidelines for blood grouping and blood transfusion. (hemotherapy)]. Cologne: Deutscher Ärzteverlag, 1996.
14. Guide to the use, preparation and quality control of blood components: recommendation No. R(95) 15. 3rd ed. Strasbourg: Council of Europe, 1997.
15. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224-32.
16. Zingsem J, Zimmermann R, Weisbach V, et al. Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors. Transfusion 1997;37:1045-9.
17. Fournel JJ, Zingsem J, Riggert J, et al. A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets. Transfusion 1997;37:487-92.
18. Moog R, Muller N, Goergens D. Platelet collection with the Amicus and the AS.TEC 204 blood cell separators. Transfusion 1998;38:285-9.
19. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992;72:449-89.
20. Vannucchi AM, Bosi A, Linari S, et al. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study. Haematologica 1997;82:53-6.
21. Koller MR, Bradley MS, Palsson BO. Growth factor consumption and production in perfusion cultures of human bone marrow correlate with specific cell production. Exp Hematol 1995;23:1275-83.
22. Corash L, Chen HY, Levin J, et al. Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume. Blood 1987;70:177-85.
23. Miller ME, Cronkite EP, Garcia JF. Plasma levels of immunoreactive erythropoietin after acute blood loss in man. Br J Haematol 1982;52:545-9.
24. Borge OJ, Ramsfjell V, Veiby OP, et al. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. Blood 1996;88:2859-70.